Goiter
📧 Sign up to get email alerts when something new happens for Goiter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease [NA]
This clinical trial update describes the ThyMoves program, an exercise- and screening-based study designed to improve muscle strength, quali…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System [NA]
A prospective evaluation of the nPulse Vybrance Percutaneous Electrode System for thyroid nodule/goiter ablation is currently recruiting in …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Thyroid Artery Embolization for the Treatment of Compressive Goiters. [NA]
A recruiting clinical trial is investigating thyroid artery embolization as a treatment for compressive goiters caused by thyroid nodules.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for Large Thyroid Nodules [NA]
A pilot clinical trial is evaluating thyroid artery embolization as a treatment for large benign thyroid nodules and goiter, with recruitmen…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Dysphagia After Thyroidectomy
A recruiting clinical trial from Istituto Auxologico Italiano is investigating dysphagia after thyroidectomy in people with goiter or thyroi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Superficial Cervical Plexus Block With Dexmedetomidine Versus Without Adjuvant in Thyroid Surgery [NA]
A completed clinical trial comparing dexmedetomidine as an adjuvant to a superficial cervical plexus block for thyroid surgery versus no adj…
-
CLINICAL_TRIALS withdrawal · 2025-10-02Clinical Trial Update: Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
A prospective observational trial investigating carotid intima-media thickness in patients undergoing thyroid surgery has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Prospective Comparison of the Effect on Antiadhesive Barriers During Thyroid Surgery [Phase 1]
Phase 1 trial evaluating the effect of antiadhesive barriers during thyroidectomy has completed.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry
A multicenter registry update for the PROTECT trial of pressure-enabled retrograde occlusive therapy with embolization aimed at controlling …
-
FDA approval · 2025-03-05FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Fosun Pharma USA Inc.)
FDA approves Fosun Pharma USA Inc.'s Levothyroxine Sodium anhydrous as a generic product under Original ANDA for thyroid hormone replacement…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Calcium+Calcitriol Versus PTH for the Prevention of Hypocalcemia in Thyroidectomy. Randomized Clinical Trial [NA]
This randomized trial compares calcium with calcitriol versus parathyroid hormone (PTH) for preventing hypocalcemia after thyroidectomy; the…
-
FDA approval · 2024-09-16FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare's levothyroxine sodium, resulting in a generic product approval for thyroid ho…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Energy Metabolism in Thyroidectomized Patients [Phase 2]
Phase 2 clinical trial update on energy metabolism in thyroidectomized patients. The study has completed and posted results (June 14, 2024) …
-
FDA approval · 2024-02-20FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Synthroid (levothyroxine sodium) from AbbVie, resulting in changes to the product's labeling.
-
FDA approval · 2023-11-16FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)
The FDA approved a supplemental application for Levothyroxine Sodium by Alvogen, Inc., updating the regulatory status for this product under…
-
FDA label_change · 2023-07-20FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA supplemental application filed for Levothyroxine Sodium by Mylan Pharmaceuticals Inc., an approved generic, likely to address labeling c…
-
FDA approval · 2022-12-21FDA Approved: LEVOTHYROXINE SODIUM — Original Application (NorthStar RxLLC)
FDA approved the original application for levothyroxine sodium as a generic thyroid hormone replacement product from NorthStar RxLLC.
-
FDA approval · 2022-05-10FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva’s generic levothyroxine sodium product under an Original Application (ANDA 207588).
-
CLINICAL_TRIALS trial_result · 2022-01-21Clinical Trial Update: Analgesia for Thyroidectomy Using Bilateral Superficial Cervical Plexus Block With Bupivacaine Only or Adding Ketorolac to it. [Phase 2]
Phase 2 trial evaluating bilateral superficial cervical plexus block with bupivacaine alone or with ketorolac for analgesia after thyroidect…
-
FDA approval · 2021-05-17FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a Levothyroxine Sodium original application product from Hikma Pharmaceuticals USA Inc. as a thyroid hormone replacement therap…
-
FDA approval · 2020-11-05FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Levothyroxine Sodium from Mylan Pharmaceuticals under an ANDA, authorizing the change descri…
-
FDA approval · 2020-10-19FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Accord Healthcare Inc.)
FDA approved an original application for Levothyroxine Sodium from Accord Healthcare Inc. as a generic thyroid hormone replacement product.
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance [Phase 4]
Phase 4 clinical trial on levothyroxine for goiter with atypia of undetermined significance has been withdrawn.
-
FDA approval · 2019-06-03FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Levothyroxine Sodium from Lupin Pharmaceuticals, Inc. This action updates the product's labeling…
-
FDA approval · 2019-04-23FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)
FDA approved a supplemental application for Levothyroxine Sodium (Alvogen, Inc.), authorizing changes to the product labeling.